Piezoelectric bone conduction hearing implant Osia® – audiological and quality of life benefits
Otolaryngologia Polska · 24.06.2021 · 75 (6) · 11-22
DOI: 10.5604/01.3001.0014.9342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngologia Polska, erschienen am 24.06.2021. Verfasst von Joanna Marszał und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: Hearing Aids, Hearing Loss, Mixed Conductive-Sensorineural, Speech Perception, Stapes Surgery. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Nowadays, there are many options to treat hearing-impaired patients: tympanoplastic surgery, hearing aids and a wide range of implantable devices.
Aim
The aim of this study is to present the mid-term audiological and quality of life benefits after the implantation of Osia®, an active piezoelectric bone conduction hearing implant.
Material and methods: The state of the tissues in the implanted area, as well as audiological and quality of life results were analyzed at six, nine and twelve months after implantation in a group of four adult patients with bilateral mixed hearing loss (1 after bilateral canal-wall-down mastoidectomy, 2 with chronic simple otitis media and after myringoplasty in the opposite ear, 1 with bilateral otosclerosis and after stapedotomy in the opposite ear).
Results
No postoperative complications were found in any of the cases. One year after surgery the mean audiological gain in FF PTA4 (pure tone average for 0.5, 1, 2, and 4 kHz) was 52.2 ± 3.5 dB in comparison to the unaided situation, the mean speech understanding with Osia® in quiet was 90 ± 8.2% for 50 dB SPL, 98.8 ± 2.5% for 65 dB SPL and 100 ± 0% for 80 dB SPL, and the mean speech understanding with Osia® in noise was 37.5% ± 23.6 for 50 dB SPL, 93.8 ± 4.8% for 65 dB SPL and 98.8 ± 2.5% for 80 dB SPL. There was also an evident improvement in the quality of hearing as well as in the quality of life, measured by APHAB (Abbreviated Profile of Hearing Aid Benefit) and SSQ (Speech, Spatial and Qualities of Hearing Scale).
Conclusions
The Osia® is an effective treatment option for patients with bilateral mixed hearing loss. The mid-term audiological and quality of life results are excellent, but further observations including bigger groups of patients and a longer follow- -up are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, Poznan, Poland.
- Medicus sp. z o.o., Wrocław, Poland.
Zitieren
APA
Marszał, J., Gibasiewicz, R., Błaszczyk, M., Gawłowska, M., & Gawęcki, W. (2021). Piezoelectric bone conduction hearing implant Osia® – audiological and quality of life benefits. Otolaryngologia Polska, 75(6), 11-22. https://doi.org/10.5604/01.3001.0014.9342
Vancouver
Marszał J, Gibasiewicz R, Błaszczyk M, Gawłowska M, Gawęcki W. Piezoelectric bone conduction hearing implant Osia® – audiological and quality of life benefits. Otolaryngologia Polska. 2021;75(6):11-22. doi:10.5604/01.3001.0014.9342
BibTeX
@article{Marsza2021,
author = {Marszał, Joanna and Gibasiewicz, Renata and Błaszczyk, Magdalena and Gawłowska, Maria and Gawęcki, Wojciech},
title = {Piezoelectric bone conduction hearing implant Osia® – audiological and quality of life benefits},
journal = {Otolaryngologia Polska},
year = {2021},
volume = {75},
number = {6},
pages = {11--22},
doi = {10.5604/01.3001.0014.9342}
}
EUVIMED